UK consensus on normal tissue dose constraints for stereotactic radiotherapy
Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open. Many of these involve the treatment of oligometastatic disease at different locations in the body. Members of all the trial management groups collaborated to generate a consensus document on appropriate organ...
Những tác giả chính: | Hanna, G, Murray, L, Patel, R, Jain, S, Aitken, K, Franks, K, van As, N, Tree, A, Hatfield, P, Harrow, S, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Eaton, D, Hawkins, M |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Elsevier
2017
|
Những quyển sách tương tự
-
UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus
Bằng: Hanna, G, et al.
Được phát hành: (2016) -
Stereotactic body radiotherapy for liver metastases.
Bằng: Aitken, K, et al.
Được phát hành: (2015) -
Stereotactic body radiotherapy for oligometastases.
Bằng: Tree, A, et al.
Được phát hành: (2013) -
A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
Bằng: Khoo, V, et al.
Được phát hành: (2018) -
CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
Bằng: Khoo, V, et al.
Được phát hành: (2017)